SCHEMBL23547261

SCHEMBL23547261

COc1ccc(NS(C)(=O)=O)cc1[C@H]1C[C@@H](c2ccc(Cl)cc2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 8/20 0.53
KDM1A O60341 6/20 0.50
PGR P06401 4/20 0.45
NR3C2 P08235 4/20 0.45
KIF11 P52732 1/20 0.43
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
SLC6A3 Q01959 2/20 0.43
CYP17A1 P05093 1/20 0.43
MAOA P21397 4/20 0.42
MAOB P27338 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
BRD4 O60885 1/20 0.41
AR P10275 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23547249 1.00 NR3C1 (0.53) NR3C1KDM1APGRNR3C2KIF11
SCHEMBL23525700 1.00 NR3C1 (0.53) NR3C1KDM1APGRNR3C2KIF11
SCHEMBL23525695 0.81 NR3C1 (0.43) NR3C1KDM1APGRNR3C2KIF11
SCHEMBL23525739 0.81 NR3C1 (0.56) NR3C1KDM1APGRNR3C2CYP17A1
SCHEMBL23547250 0.81 NR3C1 (0.56) NR3C1KDM1APGRNR3C2CYP17A1
SCHEMBL23547263 0.81 NR3C1 (0.56) NR3C1KDM1APGRNR3C2CYP17A1
SCHEMBL23547267 0.81 NR3C1 (0.43) NR3C1KDM1APGRNR3C2KIF11
SCHEMBL3378288 0.73 KIF11 (0.59) NR3C1KDM1APGRNR3C2KIF11
SCHEMBL23547256 0.72 PPARG (0.44) KDM4EMAPT
SCHEMBL23547254 0.72 PPARG (0.44) KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210188775-A1 CARBOXAMIDE AND SULFONAMIDE DERIVATIVES USEFUL AS TEAD MODULATORS GENENTECH, INC. (US) 2021-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188775-A1 CARBOXAMIDE AND SULFONAMIDE DERIVATIVES USEFUL AS TEAD MODULATORS TEAD2, TEAD1, SULT2A1 NR3C1 4525/4885KDM1A 541/4885PGR 4346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.